Rankings
▼
Calendar
CRIS (Curis, Inc.) Stock Financials & Earnings | Market Cap Arena
CRIS
Curis, Inc.
Mkt Cap
$15M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$12M
Net Income (TTM)
-$37M
EPS (TTM)
-$3.67
Free Cash Flow (TTM)
-$30M
Gross Margin
99.5%
Op. Margin
-294.6%
Net Margin
-313.8%
FCF Margin
-258.3%
P/S Ratio (TTM)
1.3x
P/E Ratio (TTM)
—
YoY Rev Growth
+13.6%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 17
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$3M
$3M
-$10M
Q1 23
$2M
$2M
-$12M
Q2 23
$2M
$2M
-$12M
Q3 23
$3M
$3M
-$12M
Q4 23
$3M
$3M
-$12M
Q1 24
$2M
$2M
-$12M
Q2 24
$3M
$3M
-$13M
Q3 24
$3M
$3M
-$11M
Q4 24
$3M
$3M
-$9M
Q1 25
$2M
$2M
-$10M
Q2 25
$3M
$3M
-$8M
Q3 25
$3M
$3M
-$7M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
1.5x
—
Q1 23
1.4x
—
Q2 23
1.5x
—
Q3 23
1.5x
—
Q4 23
1.5x
—
Q1 24
1.5x
—
Q2 24
1.5x
—
Q3 24
1.5x
—
Q4 24
1.4x
—
Q1 25
1.3x
—
Q2 25
1.3x
—
Q3 25
1.3x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$12M
-$12M
Q1 23
-$12M
-$12M
Q2 23
-$8M
-$8M
Q3 23
-$8M
-$8M
Q4 23
-$10M
-$10M
Q1 24
-$13M
-$13M
Q2 24
-$11M
-$11M
Q3 24
-$6M
-$6M
Q4 24
-$9M
-$9M
Q1 25
-$7M
-$7M
Q2 25
-$8M
-$8M
Q3 25
-$6M
-$6M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$0
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$0
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-7.9%
-16.5%
Q1 23
+11.7%
-19.0%
Q2 23
-8.2%
-17.9%
Q3 23
+0.3%
-1.5%
Q4 23
-6.6%
+13.6%
Q1 24
-9.2%
+4.5%
Q2 24
+15.9%
+5.0%
Q3 24
+3.5%
-11.2%
Q4 24
+24.1%
-17.2%
Q1 25
+14.1%
-13.9%
Q2 25
+8.0%
-26.9%
Q3 25
+8.4%
-25.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$2M
60.4%
Q1 23
$1M
60.7%
Q2 23
$0
0.0%
Q3 23
$2M
57.6%
Q4 23
$2M
57.4%
Q1 24
$0
0.0%
Q2 24
$2M
66.9%
Q3 24
$1M
47.2%
Q4 24
$1M
38.3%
Q1 25
$1M
48.9%
Q2 25
$1M
41.3%
Q3 25
$924K
29.1%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$9M
$4M
Q1 23
$9M
$5M
Q2 23
$10M
$4M
Q3 23
$10M
$5M
Q4 23
$10M
$5M
Q1 24
$10M
$5M
Q2 24
$10M
$5M
Q3 24
$10M
$4M
Q4 24
$9M
$3M
Q1 25
$9M
$4M
Q2 25
$7M
$4M
Q3 25
$6M
$4M
marketcaparena.com
Revenue Segments
Contra Revenue
Gross Royalty Revenue
Reportable Segment
Quarter
Contra Revenue
Gross Royalty Revenue
Reportable Segment
Q4 22
-$14K
$3M
—
Q1 23
—
$2M
—
Q2 23
—
$2M
—
Q3 23
—
$3M
—
Q4 23
—
$3M
—
Q1 25
—
—
$2M
Q2 25
—
—
$3M
Q3 25
—
—
$3M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$20M
$66M
$86M
Q1 23
$32M
$40M
$72M
Q2 23
$20M
$44M
$63M
Q3 23
$24M
$44M
$68M
Q4 23
$27M
$30M
$56M
Q1 24
$30M
$11M
$41M
Q2 24
$10M
$18M
$28M
Q3 24
$21M
$0
$21M
Q4 24
$20M
$0
$20M
Q1 25
$20M
$0
$20M
Q2 25
$10M
$0
$10M
Q3 25
$9M
$0
$9M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
5M
+2.8%
Q1 23
5M
+0.2%
Q2 23
5M
+0.1%
Q3 23
6M
+18.3%
Q4 23
6M
+0.9%
Q1 24
6M
+0.2%
Q2 24
6M
+0.6%
Q3 24
6M
+2.1%
Q4 24
8M
+29.1%
Q1 25
8M
+10.7%
Q2 25
13M
+48.7%
Q3 25
16M
+24.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 13
$455K
33
FY 14
$281K
35
FY 15
$179K
44
FY 16
$130K
58
FY 17
$180K
55
FY 18
$336K
31
FY 19
$357K
28
FY 20
$387K
28
FY 21
$177K
60
FY 22
$199K
51
FY 23
$205K
49
FY 24
$321K
34
marketcaparena.com